| ERNST | European Resuscitation Nimodipine Study |
|---|
| Nim | Nimodipine |
|---|
| nimodipine | <chemical> A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects, lowers blood pressure, and is effective in the therapy and/or prevention of cerebral vasospasm caused by stroke, cerebral haemorrhage, aneurysm, severe head injury, or cerebral ischemia. Pharmacological action: antihypertensive agents, calcium channel blockers, vasodilator agents. Chemical name: 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-methoxyethyl 1-methylethyl ester (12 Dec 1998) |
|---|
Synonyms : Admon, Almirall Brand of Nimodipine, Alpharma Brand of Nimodipine, Andromaco Brand of Nimodipine, Bay e 9736, Bayer Brand of Nimodipine, Bayvit Brand of Nimodipine, Brainal, Calnit, Cantabria Brand of Nimodipine, Elan Brand of Nimodipine, Kenesil, Modus, Nimotop
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|---|---|---|---|
|
니모톱정주 - 새창
|
바이엘 독일 |
E00280211 | Nimodipine | 전문의약품 | 급여 |
|
이연니모디핀주 - 새창
|
이연제약 |
A01401521 | Nimodipine | 전문의약품 | 급여 | 분업예외의약품 |
|
보령니모디핀주10mg - 새창
|
보령제약 |
A09303261 | Nimodipine | 전문의약품 | 급여 | 분업예외의약품 |
|
삼진니모디핀주 - 새창
|
삼진제약 |
A12702141 | Nimodipine | 전문의약품 | 급여 | 분업예외의약품 |
|
니모톱정30mg - 새창
|
한독약품 |
B05500141 | Nimodipine | 전문의약품 | 급여 |
|
브레딘정 - 새창
|
신풍제약 |
A00304201 | Nimodipine | 전문의약품 | 삭제 |
|
보령니모디핀정30mg - 새창
|
보령제약 |
A09303251 | Nimodipine | 전문의약품 | 급여 |
|
이연니모디핀정 - 새창
|
이연제약 |
A01401511 | Nimodipine | 전문의약품 | 급여 |
|
삼진니모디핀정 - 새창
|
삼진제약 |
A12702121 | Nimodipine | 전문의약품 | 급여 |
|
세레보날정 - 새창
|
영풍제약 |
A25003781 | Nimodipine | 전문의약품 | 급여 |
| nimodipine |
Belongs to a group of drugs known as calcium channel blockers. It is being investigated for use with chemotherapy to prevent or overcome drug resistance and improve response to chemotherapy.
출처: nydailynews.healthology.com/nydailynews/15836.htm
|
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
